Abstract

BackgroundThe aim of the present study was to evaluate the effects of glucosamine-chondroitin sulphate combination on internal derangements of temporomandibular joint in clinical and biochemical manners.Material and MethodsThis randomized clinical study included 31 cases reporting joint tenderness, in which disc displacement was detected on MR imaging. In all patients, synovial fluid sampling was performed under local anesthesia. In the study group, the patients were prescribed a combination of 1500 mg glucosamine and 1200 mg chondroitin sulphate, while patients in the control group were only prescribed 50 mg tramadol HCl (twice daily) for pain control. After 8 weeks, synovial fluid sampling was repeated in the same manner. The levels of pain, maximum mouth opening (MMO), synovial fluid IL-1ß, IL-6, TNF-α and PGE2 measured before and after pharmacological intervention were compared.ResultsThe reduction in pain levels was significant in both groups. There was no significant difference between two groups in terms of pain reduction. The improvement in MMO was significant in the study group but it was not in the control group. The MMO improvement was significantly higher in the study group compared to the control group. In the study group, significant decrease was observed in PGE2 level, while the decreases in IL-1β, IL-6 and TNF-α levels were not significant. In the control group, no significant decrease was observed in any of the inflammatory cytokines after 8 weeks, moreover IL-1ß and IL-6 levels were increased. Alterations of IL-1ß and IL-6 levels were significant in study group while TNF-α and PGE2 levels were not, compared to control group.ConclusionsIn conclusion, these results might suggest that glucosamine-chondroitin combination significantly increases the MMO and decreases the synovial fluid IL1β and IL6 levels in internal derangements of TMJ compared to tramadol. The modifications of synovial fluid TNF-α and PGE2 levels do not reach statistical significance. This combination also provides efficient pain relief in similar level with tramadol, a narcotic analgesic. Key words: Chondroitin sulphate, glucosamine, internal derangement, TMJ, tramadol.

Highlights

  • Temporomandibular joint (TMJ) disorders become increasingly common in society over years

  • In this randomized, double-blinded, controlled clinical study, we evaluated the effects of glucosamine-chondroitin sulphate combination on synovial fluid IL-1ß, interleukin 6 (IL-6), TNF-α and prostaglandin E2 (PGE2) levels in internal derangement of TMJ

  • A decrease was observed in the sound and pain of joints in patients taking glucosamine and chondroitin sulphate but authors suggested that a double-blinded study with non-steroid anti-inflammatory (NSAI) control would provide more significant results

Read more

Summary

Introduction

Temporomandibular joint (TMJ) disorders become increasingly common in society over years. The aim of the present randomized clinical study was to evaluate the effects of glucosamine chondroitin sulphate combination on the internal derangements of temporomandibular joint and to compare the effects of this combination with tramadol, a narcotic analgesic, in clinical and biochemical manners. The aim of the present study was to evaluate the effects of glucosamine-chondroitin sulphate combination on internal derangements of temporomandibular joint in clinical and biochemical manners. Conclusions: In conclusion, these results might suggest that glucosamine-chondroitin combination significantly increases the MMO and decreases the synovial fluid IL1β and IL6 levels in internal derangements of TMJ compared to tramadol. The modifications of synovial fluid TNF-α and PGE2 levels do not reach statistical significance This combination provides efficient pain relief in similar level with tramadol, a narcotic analgesic

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call